$17.060
-0.295 (-1.73%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RLAY-Prognose durch Analyse ähnlicher Charts
Alphio's RLAY stock price prediction model matches the current Relay Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.95 (-0.63%). The 1-week path is $17.00 (-0.35%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Relay Therapeutics Inc-Aktien kaufen?
Relay Therapeutics Inc is a good buy right now due to its current price of $17.88, which is significantly lower than the analyst price target of $31, indicating a potential upside of 73%. Additionally, despite recent insider selling, the stock has appreciated 485% over the past year, reflecting strong investor confidence in its drug development pipeline. The main risk is the negative net income, which was reported at -$73,291,000 for Q1 2026, indicating ongoing financial challenges that could impact future performance.
RLAY schloss am Wednesday bei $17.06, nachdem der Kurs -1.73% fallen
Relay Therapeutics Inc (RLAY) last closed at $17.06, losing -1.73%. These facts feed the 1-day and 1-week RLAY price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Relay Therapeutics Inc (RLAY) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RLAY am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RLAY
Historically the probability of a positive October return for RLAY is 59.65%. October offers the highest probability of a positive month at 59.65%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.